Patients with Down syndrome and congenital heart disease: survival is improving, but challenges remain
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Contributors Both authors have contributed in drafting the manuscript.
Competing interests KD has received unrestricted education grants and has acted as a consultant for Actelion, GSK, Pfizer and Bayer.
Provenance and peer review Commissioned; internally peer reviewed.